Home
Tatva Chintan Pharma Chem Ltd Share Price History
Tatva Chintan Pharma Chem Ltd
NSE : 17 Apr, 2025
7220.3 (0.0%)
Prev Close
721.8
Open Price
721.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
25402
Today's High / Low
735.0 / 717.1
52 WK High / Low
1283.7 / 621.0
Market Price of Tatva Chintan Pharma Chem Ltd
1M
1Y
3Y
5Y
Monitoring Tatva Chintan Pharma Chem Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2018 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 15.29 |
| YoY Gr. | - |
| Net Profit (Cr.) | 12 |
| BVPS | 73.57 |
Key Financial Parameters
| Parameter | 2018 |
|---|---|
| Return on Capital Emp. % | 18.77 |
| Op. Profit Mgn % | 18.13 |
| Net Profit Mgn % | 9.05 |
| Debt to Equity % | 0.95 |
Latest Shareholding
Promoters Holdings Over Time
About Tatva Chintan Pharma Chem Ltd
- Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
- The status of the Company converted from Private Limited into a Public Limited Company effective from 27 January 2021 and the name of Company also changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
- The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
- The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), , Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).
Popular Search
FAQs for Tatva Chintan Pharma Chem Ltd Share Price History
What are the key events that typically impact Tatva Chintan Pharma Chem Ltd's share price history?
Key events that impact Tatva Chintan Pharma Chem Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Tatva Chintan Pharma Chem Ltd's share price history?
Stock splits reduce the nominal price of Tatva Chintan Pharma Chem Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Tatva Chintan Pharma Chem Ltd?
Dividends can influence Tatva Chintan Pharma Chem Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Tatva Chintan Pharma Chem Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Tatva Chintan Pharma Chem Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Tatva Chintan Pharma Chem Ltd’s share price history?
To understand Tatva Chintan Pharma Chem Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
